Sigyn Therapeutics, Inc. (SIGY)
OTCMKTS
· Delayed Price · Currency is USD
2.750
+0.260 (10.44%)
At close: Jun 6, 2025
Sigyn Therapeutics Market Cap
Sigyn Therapeutics has a market cap or net worth of $4.41 million as of June 26, 2025. Its market cap has decreased by -90.57% in one year.
Market Cap
4.41M
Enterprise Value
6.91M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.75
Market Cap Chart
Since October 20, 2020, Sigyn Therapeutics's market cap has decreased from 66.98M to 4.41M, a decrease of -93.41%. That is a compound annual growth rate of -44.42%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 6, 2025 | 4.41M | -12.70% |
Dec 17, 2024 | 5.06M | -16.78% |
Dec 27, 2023 | 6.08M | -4.15% |
Dec 29, 2022 | 6.34M | -66.00% |
Dec 30, 2021 | 18.65M | -57.38% |
Dec 31, 2020 | 43.76M | -34.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Endo, Inc. | 1.59B |
Elite Pharmaceuticals | 827.70M |
Veradigm | 764.23M |
Nika Pharmaceuticals | 708.22M |
Tian'an Technology Group | 628.15M |
American Oncology Network | 420.90M |
Glass House Brands | 389.15M |
CytoDyn | 386.66M |